CGL10 10mg*10vials

Cagrilintide CGL10 10mg*10vials

Cagrilintide is an amylin analog research peptide designed to modulate appetite and satiety signaling pathways, representing a high-concentration metabolic research compound.

The 10mg single-vial specification delivers double the active ingredient content of the standard 5mg. This formulation is ideal for long-term appetite regulation studies, high-dose amylin pathway experiments, and researchers conducting extended large-animal research. The higher concentration per vial significantly reduces the number of vials needed for prolonged experiments, minimizing handling variables and operational errors from repeated dilution.

Through amylin receptor activation, Cagrilintide supports in-depth research into satiety signaling, food intake regulation, and appetite-related metabolic pathways. It is designed to investigate how amylin pathway modulation can influence appetite control and metabolic homeostasis research applications across extended study durations.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Every batch undergoes rigorous purity testing, with a complete certificate of analysis provided.

10 vials per pack, designed for long-term preclinical research and high-intensity appetite regulation laboratory projects.